Cost-Effectiveness of Conventionally-Fractionated, Hypofractionated, and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer-MedSci.cn

Cost-Effectiveness of Conventionally-Fractionated, Hypofractionated, and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer

Parikh, NR; Nickols, NG; Loblaw, DA; Zaorsky, NG; Hollenbeak, C; Kupelian, PA; Steinberg, ML; Spratt, DE; Kishan, AU

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020; 108 (3): E402

科室
- - 订阅+
  - 更多科室
工具
服务